HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 604 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,142,000 | -27.8% | 27,155 | -35.9% | 0.00% | 0.0% |
| Q2 2023 | $4,354,000 | -84.4% | 42,336 | -83.4% | 0.00% | -87.5% |
| Q1 2023 | $27,859,000 | +133.7% | 255,272 | +143.7% | 0.01% | +166.7% |
| Q4 2022 | $11,919,000 | +30.4% | 104,736 | -29.1% | 0.00% | 0.0% |
| Q3 2022 | $9,138,000 | +0.8% | 147,655 | +29.9% | 0.00% | 0.0% |
| Q2 2022 | $9,064,000 | -54.5% | 113,631 | -40.0% | 0.00% | -40.0% |
| Q1 2022 | $19,930,000 | +46.7% | 189,437 | +50.3% | 0.01% | +66.7% |
| Q4 2021 | $13,581,000 | +6.3% | 126,040 | +8.1% | 0.00% | 0.0% |
| Q3 2021 | $12,776,000 | -14.5% | 116,634 | -26.9% | 0.00% | -25.0% |
| Q2 2021 | $14,941,000 | +66.8% | 159,574 | +64.0% | 0.00% | +33.3% |
| Q1 2021 | $8,955,000 | +165.3% | 97,300 | +110.8% | 0.00% | +200.0% |
| Q4 2020 | $3,376,000 | +36.7% | 46,148 | +45.3% | 0.00% | 0.0% |
| Q3 2020 | $2,469,000 | +70.2% | 31,770 | +21.6% | 0.00% | 0.0% |
| Q2 2020 | $1,451,000 | +273.0% | 26,119 | +98.8% | 0.00% | – |
| Q1 2020 | $389,000 | -29.3% | 13,141 | -13.5% | 0.00% | – |
| Q4 2019 | $550,000 | +69.2% | 15,200 | +27.0% | 0.00% | – |
| Q3 2019 | $325,000 | -18.1% | 11,966 | -27.4% | 0.00% | – |
| Q2 2019 | $397,000 | – | 16,490 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |